Trial
NCT03343847
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma.
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Amgen
Collaborators
—
Condition
Chemotherapy-induced Thrombocytopenia
Intervention
Romiplostim
Why stopped
Study was not feasible
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-19